div class=trans-pagebutton class=gotoPage data-page=1Page 1button div class=trans-imageimg data-url=document20170-durvalumab-tremelimumab-vs-durvalumab-vs-tremelimumab-in-i-icc-arm-htmlpage=1 data-page=1 class=trans-thumb lazyload alt=Page 1: oncoletter 20170… · Durvalumab + Tremelimumab vs Durvalumab vs Tremelimumab in I-ICC Arm + n=36 12 subjoctstviral status typo ASCO 2016 Abstract 4012 2017 Gastrointestinal loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader034fdocumentsinreader034viewer20220429185f5f704e4d90a4611a482179html5thumbnails1jpg width=140 height=200 divdivdiv class=trans-pagebutton class=gotoPage data-page=2Page 2button div class=trans-imageimg data-url=document20170-durvalumab-tremelimumab-vs-durvalumab-vs-tremelimumab-in-i-icc-arm-htmlpage=2 data-page=2 class=trans-thumb lazyload alt=Page 2: oncoletter 20170… · Durvalumab + Tremelimumab vs Durvalumab vs Tremelimumab in I-ICC Arm + n=36 12 subjoctstviral status typo ASCO 2016 Abstract 4012 2017 Gastrointestinal loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader034fdocumentsinreader034viewer20220429185f5f704e4d90a4611a482179html5thumbnails2jpg width=140 height=200 divdivdiv class=trans-pagebutton class=gotoPage data-page=3Page 3button div class=trans-imageimg data-url=document20170-durvalumab-tremelimumab-vs-durvalumab-vs-tremelimumab-in-i-icc-arm-htmlpage=3 data-page=3 class=trans-thumb lazyload alt=Page 3: oncoletter 20170… · Durvalumab + Tremelimumab vs Durvalumab vs Tremelimumab in I-ICC Arm + n=36 12 subjoctstviral status typo ASCO 2016 Abstract 4012 2017 Gastrointestinal loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII=...